GGHC
TGTX icon

Gilder Gagnon Howe & Co’s TG Therapeutics TGTX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,393
Closed -$608K – 275
2025
Q4 		$608K Sell
20,393
-50,968
-71% -$1.66M 0.01% 231
2025
Q3 		$2.58M Buy
71,361
+51
+0.1% +$1.68K 0.03% 186
2025
Q2 		$2.57M Sell
71,310
-9,467
-12% -$352K 0.03% 170
2025
Q1 		$3.19M Sell
80,777
-515
-0.6% -$17.3K 0.04% 155
2024
Q4 		$2.45M Buy
81,292
+16,394
+25% +$470K 0.03% 180
2024
Q3 		$1.52M Buy
64,898
+4,225
+7% +$92.3K 0.02% 195
2024
Q2 		$1.08M Buy
+60,673
New +$968K 0.01% 203

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return